Valuation dashboard for Radiopharm Theranostics Limited (RADX) with P/E N/A, P/B 2.21, EV/EBITDA -1.01 and dividend yield 0.00%. DCF, Graham Number and Earnings Power Value models plus sector comparison against other Healthcare companies.
Radiopharm Theranostics Limited, an Australian company established in Carlton in 2021, specializes in the research and development of cutting-edge radiopharmaceutical treatments. Their mission is to address critical gaps in healthcare by creating products for both diagnostic imaging and therapeutic intervention across a spectrum of challenging medical conditions.
Analysis Summary
Trailing-twelve-month margins: gross margin -77.7%, operating margin -24.7%, net margin -19.9%.
At the current price of $1.67, RADX has negative trailing earnings (P/E not meaningful) and an ROE of -218.50%. Market capitalisation stands at $2M.
Balance sheet quality for RADX: current ratio of 1.2. A debt-to-equity below 1.0 typically signals conservative capital structure, while a current ratio above 1.5 indicates comfortable short-term liquidity.
Valuation Ratios
| Price / Book | 2.21 |
| EV / EBITDA | -1.01 |
| Dividend Yield | 0.00% |
Peer Comparison
| Symbol | Company | Market Cap | P/E | P/B | ROE |
|---|---|---|---|---|---|
| RADX | Radiopharm Theranostics Limited | $2M | 2.21 | -218.5% | |
| 0QZU.L | Vertex Pharmaceuticals Incorporated | $131.8B | |||
| VRTX | Vertex Pharmaceuticals Incorporated | $130.3B | 29.68 | 6.45 | 23.3% |
| 0R2M.L | Regeneron Pharmaceuticals, Inc. | $84.0B | |||
| REGN | Regeneron Pharmaceuticals, Inc. | $79.8B | 18.79 | 2.57 | 13.8% |
| ARGX | argenx SE | $61.2B | 36.30 | 7.40 | 21.7% |
| MRNA | Moderna, Inc. | $57.8B | 1.34 | -39.2% | |
| RVMD | Revolution Medicines, Inc. | $41.7B | 15.96 | -96.4% |
Price
| Price | $1.67 |
| Market Cap | $2M |
| Exchange | NASDAQ |
| Country | AU |
Profitability
| Return on Equity | -218.50% |
| Return on Invested Capital | -161.91% |
| Return on Assets | -89.70% |
| Gross Margin | -77.67% |
| Operating Margin | -2468.62% |
| Net Margin | -1992.46% |
Related companies: ADXN · BCLI · CDIO · CYCN · IBO · KTTA · MTNB
Explore sector: Healthcare · Biotechnology
More sections of RADX: Overview · Financials · Statistics · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks